Literature DB >> 12360073

Xanthelasma palpebrarum: a review and current management principles.

Rod J Rohrich1, Jeffrey E Janis, Patrick H Pownell.   

Abstract

LEARNING
OBJECTIVES: After studying this article, the participant should be able to: 1. Describe the differential diagnosis of xanthelasma palpebrarum. 2. Discuss the various nonsurgical and surgical treatment options and their advantages and disadvantages. 3. Describe the circumstances in which recurrence is most likely after treatment. Xanthelasma palpebrarum is the most common cutaneous xanthoma. It typically presents in middle-aged and older adults, most often around the eyelids. The diagnosis can often be made on clinical grounds alone. For the plastic surgeon, it is important to apply an algorithmic approach to the treatment of these lesions. Depending on the size and location, several different methods can be used to address this problem, ranging from simple excision, to laser treatment, to chemical peeling. This article addresses the underlying pathophysiology of xanthelasma and the currently accepted modes of treatment.

Entities:  

Mesh:

Year:  2002        PMID: 12360073     DOI: 10.1097/01.PRS.0000025626.70065.2B

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  14 in total

1.  Laser treatment of giant xanthelasma palpebrarum.

Authors:  Bartolo Corradino; Sara Di Lorenzo; Antonio Triolo; Francesco Moschella
Journal:  Lasers Med Sci       Date:  2014-09-25       Impact factor: 3.161

2.  Inflammatory Mediators in Xanthelasma Palpebrarum: Histopathologic and Immunohistochemical Study.

Authors:  Maria S Govorkova; Tatyana Milman; Gui-Shuang Ying; Wei Pan; Rona Z Silkiss
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2018 May/Jun       Impact factor: 1.746

3.  Disappearance of eyelid xanthelasma following oral simvastatin (Zocor).

Authors:  C L Shields; A Mashayekhi; J A Shields; P Racciato
Journal:  Br J Ophthalmol       Date:  2005-05       Impact factor: 4.638

4.  Bilateral circular xanthelasma palpebrarum.

Authors:  Jungmin Kim; Yu Jin Kim; Hyoseob Lim; Se Il Lee
Journal:  Arch Plast Surg       Date:  2012-07-13

5.  Bilateral extensive nodular xanthelasma palpebrarum: an infrequent case report.

Authors:  Pei Wang; Qingli Luo; Li Tang
Journal:  Int Ophthalmol       Date:  2017-04-03       Impact factor: 2.031

6.  Periorbital Hyperpigmentation in Patients with Xanthelasma Palpebrarum: An Interesting Observation.

Authors:  Eftychia Platsidaki; Anargyros Kouris; Efthymia Agiasofitou; Christina Antoniou; Georgios Kontochristopoulos
Journal:  J Clin Aesthet Dermatol       Date:  2016-04-01

7.  Serum lipid profile and clinical characteristics of patients with xanthelasma palpebrarum.

Authors:  Hossein Kavoussi; Ali Ebrahimi; Mansour Rezaei; Mazaher Ramezani; Behnaz Najafi; Reza Kavoussi
Journal:  An Bras Dermatol       Date:  2016 Jul-Aug       Impact factor: 1.896

8.  [Eruptive xanthomas with hypertriglyceridemia].

Authors:  R Renner; I Teuwen; W Harth; R Treudler; J C Simon
Journal:  Hautarzt       Date:  2008-12       Impact factor: 0.751

9.  Outcomes of surgical management of xanthelasma palpebrarum.

Authors:  Hoon Young Lee; Ung Sik Jin; Kyung Won Minn; Young-Oh Park
Journal:  Arch Plast Surg       Date:  2013-07-17

Review 10.  Xanthelasma palpebrarum - a brief review.

Authors:  Pragya A Nair; Rochit Singhal
Journal:  Clin Cosmet Investig Dermatol       Date:  2017-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.